Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0359720110290030224
Journal of the Korean Neurological Association
2011 Volume.29 No. 3 p.224 ~ p.226
Intrathecal Chemotherapy Related Myelopathy Improved with Folate and Cyanocobalamin
Park Su-Yeon

Park Hye-ri
Kim Jee-Eun
Sung Jung-Joon
Abstract
Intrathecal chemotherapy with methotrexate and cytarabine arabinoside is used for the treatment and prophylaxis of malignancies, but can induce myelopathy. We report the case of a 50-year-old woman with stomach cancer who developed myelopathy after administration of intrathecal cytarabine arabinoside and methotrexate. The patient¡¯s neurologic status improved rapidly after the administration of folinate (15 mg) four times daily and cyanocobalamin (100 ¥ìg) once daily. The folate metabolites may be effective in the management of intrathecal-chemotherapy-induced myelopathy.
KEYWORD
Intrathecal chemotherapy, Myelopathy, Folate metabolites
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø